INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio update as at 30 April 2010
|
Total Net Assets |
£106.3m |
|
NAV per share |
173.6p |
|
Share Price |
140.3p |
|
Total value of unquoted investments |
£23.0m |
|
Total number of portfolio companies |
58 |
|
Cash |
4% |
|
Cash committed and reserved to unquoted investments |
14% |
|
Portfolio companies with < 1 year of cash |
7% |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
7.01 |
|
Micromet |
5.83 |
|
Amgen |
5.49 |
|
Shire |
4.63 |
|
Alexion Pharmaceuticals |
3.86 |
|
Gilead Sciences |
3.64 |
|
Genzyme |
3.40 |
|
EUSA Pharma |
2.88 |
|
Oxagen |
2.74 |
|
Wright Medical Group |
2.67 |
|
|
----------- |
|
Total |
42.15 |
|
Geographical Allocation |
% |
|
United States |
76 |
|
Europe |
18 |
|
Cash |
4 |
|
Australia |
2 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
74 |
|
Unquoted |
22 |
|
Cash |
4 |
|
|
----------- |
|
|
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
20 MAY 2010